Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5003155

Cc1cccc(-c2ccccc2CN)c1.O=C(O)C(F)(F)F

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 2/20 0.50
FFAR1 O14842 1/20 0.50
FFAR4 Q5NUL3 1/20 0.50
PTGER1 P34995 2/20 0.46
PTGER4 P35408 2/20 0.46
PTGER3 P43115 2/20 0.46
PTGER2 P43116 2/20 0.46
CNR2 P34972 2/20 0.43
PTPN5 P54829 2/20 0.42
HTR7 P34969 1/20 0.41
PDK2 Q15119 1/20 0.41
AKR1C3 P42330 1/20 0.40
AKR1C2 P52895 1/20 0.40
CNR1 P21554 1/20 0.40
HSD17B10 Q99714 1/20 0.40
CMA1 P23946 1/20 0.39
CTRC Q99895 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
MCL1 Q07820 1/20 0.39
BAD Q92934 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3787422 0.85 DPP4 (0.62) DPP4FFAR1FFAR4HTR7NOS3
Trifluoroacetic Acid SCHEMBL4612214 0.81 DPP4 (0.39) DPP4FFAR1FFAR4PDK2
Trifluoroacetic Acid SCHEMBL4629336 0.79 FFAR1 (0.45) DPP4FFAR1FFAR4PDK2TPH1
SCHEMBL13525193 0.77 PTGER4 (0.75) FFAR1FFAR4PTGER1PTGER4PTGER3
SCHEMBL9890647 0.77 PTGER1 (0.57) FFAR1FFAR4PTGER1PTGER4PTGER3
Trifluoroacetic Acid SCHEMBL30332231 0.74 FABP4 (0.46) DPP4PTGER1PTGER4PTGER3PTGER2
SCHEMBL5003162 0.74 FFAR1 (0.44) FFAR1FFAR4PTGER1PTGER4PTGER3
SCHEMBL11673570 0.74 FFAR1 (0.49) FFAR1FFAR4PTGER1PTGER4PTGER3
Bicarbonate SCHEMBL27817695 0.74 DPP4 (0.83) DPP4FFAR1FFAR4PTGER1PTGER4
SCHEMBL8368461 0.74 FOLH1 (0.61) DPP4PTGER1PTGER4PTGER3PTGER2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7456195-B2 Phenylglycinamide and pyridylglycinamide derivatives useful as anticoagulants BRISTOL-MYERS SQUIBB COMPANY (US) 2008-11-25 US disclosed
US-20070003539-A1 Phenylglycinamide and pyridylglycinamide derivatives useful as anticoagulants BRISTOL-MYERS SQUIBB COMPANY (US) 2007-01-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070003539-A1 Phenylglycinamide and pyridylglycinamide derivatives useful as anticoagulants F12, F11, F7 DPP4 285/4885FFAR1 2640/4885FFAR4 2129/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.